Skip to main content
SpringerLink
Log in

Effects of the anti-inflammatory drug salsalate on bone turnover in type 2 diabetes mellitus

  • Research Letter
  • Published:
Endocrine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. M. Janghorbani, R.M. Van Dam, W.C. Willett, F.B. Hu, Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am. J. Epidemiol. 166, 495–505 (2007)

    Article  PubMed  Google Scholar 

  2. L.J. Melton 3rd, B.L. Riggs, C.L. Leibson, S.J. Achenbach, J.J. Camp, M.L. Bouxsein, E.J. Atkinson, R.A. Robb, S. Khosla, A bone structural basis for fracture risk in diabetes. J. Clin. Endocrinol. Metab. 93, 4804–4809 (2008)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. P. Vestergaard, Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes–a meta-analysis. Osteoporos. Int. 18, 427–444 (2007)

    Article  CAS  PubMed  Google Scholar 

  4. J.C. Krakauer, M.J. McKenna, N.F. Buderer, D.S. Rao, F.W. Whitehouse, A.M. Parfitt, Bone loss and bone turnover in diabetes. Diabetes 44, 775–782 (1995)

    Article  CAS  PubMed  Google Scholar 

  5. M. Yamamoto, T. Yamaguchi, K. Nawata, M. Yamauchi, T. Sugimoto, Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes. J. Clin. Endocrinol. Metab. 97, 1277–1284 (2012)

    Article  CAS  PubMed  Google Scholar 

  6. S.E. Shoelson, J. Lee, A.B. Goldfine, Inflammation and insulin resistance. J. Clin. Investig. 116, 1793–1801 (2006)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. D. Cai, M. Yuan, D.F. Frantz, P.A. Melendez, L. Hansen, J. Lee, S.E. Shoelson, Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 11, 183–190 (2005)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. M.N. Weitzmann, S. Cenci, L. Rifas, J. Haug, J. Dipersio, R. Pacifici, T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms. J. Bone Miner. Res. 16, 328–337 (2001)

    Article  CAS  PubMed  Google Scholar 

  9. P.J. Kostenuik, V. Shalhoub, Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption. Curr. Pharm. Des. 7, 613–635 (2001)

    Article  CAS  PubMed  Google Scholar 

  10. A.B. Goldfine, V. Fonseca, K.A. Jablonski, L. Pyle, M.A. Staten, S.E. Shoelson, The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann. Intern. Med. 152, 346–357 (2010)

    Article  PubMed Central  PubMed  Google Scholar 

  11. M.J. Yin, Y. Yamamoto, R.B. Gaynor, The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396, 77–80 (1998)

    Article  CAS  PubMed  Google Scholar 

  12. A.B. Goldfine, R. Silver, W. Aldhahi, D. Cai, E. Tatro, J. Lee, S.E. Shoelson, Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin. Transl. Sci. 1, 36–43 (2008)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. J.S. Manavalan, S. Cremers, D.W. Dempster, H. Zhou, E. Dworakowski, A. Kode, S. Kousteni, M.R. Rubin, Circulating osteogenic precursor cells in type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 97, 3240–3250 (2012)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. A.G. Pittas, S.S. Harris, M. Eliades, P. Stark, B. Dawson-Hughes, Association between serum osteocalcin and markers of metabolic phenotype. J. Clin. Endocrinol. Metab. 94, 827–832 (2009)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Y. Bao, X. Ma, R. Yang, F. Wang, Y. Hao, J. Dou, H. He, W. Jia, Inverse relationship between serum osteocalcin levels and visceral fat area in Chinese men. J. Clin. Endocrinol. Metab. 98, 345–351 (2013)

    Article  CAS  PubMed  Google Scholar 

  16. S. Kiechl, J. Wittmann, A. Giaccari, M. Knoflach, P. Willeit, A. Bozec, A.R. Moschen, G. Muscogiuri, G.P. Sorice, T. Kireva, M. Summerer, S. Wirtz, J. Luther, D. Mielenz, U. Billmeier, G. Egger, A. Mayr, F. Oberhollenzer, F. Kronenberg, M. Orthofer, J.M. Penninger, J.B. Meigs, E. Bonora, H. Tilg, J. Willeit, G. Schett, Blockade of receptor activator of nuclear factor-kappaB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. Nat. Med. 19, 358–363 (2013)

    Article  CAS  PubMed  Google Scholar 

  17. N. Napoli, E. Vittinghoff, N. Pannacciulli, D. Crittenden, J. Yun, A. Wang, R. Wagman, A.V. Schwartz, Effect of denosumab on fasting glucose concentrations in postmenopausal women with osteoporosis: results from subjects with diabetes or prediabetes from the FREEDOM trial. J. Bone Miner. Res. (2014)

  18. S. Minisola, S. Dionisi, M.T. Pacitti, F. Paglia, V. Carnevale, A. Scillitani, S. Mazzaferro, G.S. De, J. Pepe, E. Derasmo, E. Romagnoli, Gender differences in serum markers of bone resorption in healthy subjects and patients with disorders affecting bone. Osteoporos. Int. 13, 171–175 (2002)

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Drs. Bela F. Asztalos, Masumi Ai, and Ernst J. Schaefer of the Lipid Metabolism Laboratory, Tufts University, Boston, MA for measuring the adiponectin, insulin, C- peptide, and CRP. Support for this work was provided by program Grant PO50HL083813 from the National Institutes of Health.

Conflict of interest

The authors do not have any conflicts of interest.

Funding

NIH Grants RC4 DK090776, U01 DK74556, P50 HL083813, K24 DK074457 and P01 DK036836.

Author information

Authors and Affiliations

  1. Metabolic Bone Diseases Unit, Department of Medicine, College of Physicians & Surgeons, Columbia University, 630 W. 168th St, New York, NY, 10032, USA

    Mishaela R. Rubin, Donald J. McMahon, Serge Cremers, Elzbieta Dworakowski & Shonni J. Silverberg

  2. Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA

    Allison B. Goldfine & Steven E. Shoelson

  3. Lipid Metabolism Laboratory, Tufts University, Boston, MA, USA

    Ernst J. Schaefer

  4. Department of Medicine, College of Physicians & Surgeons, Columbia University, 630 W. 168th St, New York, NY, 10032, USA

    Daniel S. Donovan

Authors
  1. Mishaela R. Rubin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Allison B. Goldfine
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Donald J. McMahon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniel S. Donovan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Serge Cremers
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Elzbieta Dworakowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ernst J. Schaefer
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Steven E. Shoelson
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shonni J. Silverberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mishaela R. Rubin.

Additional information

For the TINSAL-T2D Study Team.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rubin, M.R., Goldfine, A.B., McMahon, D.J. et al. Effects of the anti-inflammatory drug salsalate on bone turnover in type 2 diabetes mellitus. Endocrine 50, 504–507 (2015). https://doi.org/10.1007/s12020-015-0535-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-015-0535-8

Keywords

Search

Navigation